Donaco International Ltd

Donaco International Ltd (ASX:DNA) announces that it will release its statutory results and preliminary accounts for the financial half-year ending 31 December 2016 on Thursday, 23 February 2017.

Donaco International Ltd (ASX:DNA) announces that Crowe Horwath Sydney has been appointed as the Company's auditor.

Donaco International Limited (ASX:DNA) is pleased to provide the company's Chairman's address and Managing Director's address, to be delivered at today's Annual General Meeting of shareholders.

Donaco International Ltd (ASX:DNA) directors present their report, together with the financial statements, on the consolidated entity consisting of Donaco International and the entities it controlled at the end of, or during, the year ended 30 June 2016.

Donaco International Limited (ASX:DNA) ("Donaco" or "the Company") has lodged its financial year 2016 audited accounts, achieving an audited profit of $78.7m, compared to $77.2m which was detailed in the preliminary report (Appendix 4E) released on 30 August 2016.

The Board of Donaco International Limited (ASX:DNA) (the Company) has resolved to introduce a new Long Term Incentive (LTI) scheme for its senior executives, to replace the previous options scheme that expired at the end of FY16.

Donaco International Ltd (ASX:DNA) are pleased to provide the Company's latest Investor Presentation regarding the FY16 results.

Donaco International Limited (ASX:DNA) is pleased to announce its results for the 12 months ended 30 June 2016 (FY16), a period which saw the group transform and significantly grow in scale with the addition of the Star Vegas.

Donaco International Ltd (ASX:DNA) announces that it will release its statutory results and preliminary accounts for the financial year ending 30 June 2016 after the market closes on Tuesday, 30 August 2016.

Donaco International Limited (ASX:DNA) has refinanced its USD20 million working capital facility that was announced to the ASX on 23 June 2015 and 1 July 2015. The refinancing will save the Company approximately USD3.8 million in financing costs over the next two financial years (FY17 and FY18), compared to the cost of repaying the facility in accordance with its original terms.